BBNX Sale Disclosure
Hopman Mark · SEC Form 4 · Filed Sep 10, 2026
Sale
Calculated transaction value
$680.72K
Hopman Mark Chief Commercial Officer
BBNX
Beta Bionics
BBNX
Transaction date
Sep 9, 2026
Public filing date
Sep 10, 2026
Filing lag
Filed 1 day later
BBNX daily price context
Close on/before transaction
$17.42
Sep 9, 2026
Close before public filing
$17.42
Sep 9, 2026
Return since public filing
-3.96%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 36,870 shares @ $18.46
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002048497-26-000013
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$680.72K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Beta Bionics, Inc. BBNX Current | Sale | Sep 9, 2026 | $680.72K |